Xylem Q3 2024 Adj. EPS $1.11, Inline, Sales $2.104B Miss $2.175B Estimate
Portfolio Pulse from Benzinga Newsdesk
Xylem reported Q3 2024 earnings per share of $1.11, meeting analyst expectations, but sales of $2.104 billion fell short of the $2.175 billion estimate. Despite the sales miss, EPS increased by 12.12% from the previous year.
October 31, 2024 | 11:00 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Xylem's Q3 2024 earnings per share met expectations at $1.11, but sales missed estimates, coming in at $2.104 billion versus the expected $2.175 billion. Despite the sales miss, EPS showed a significant year-over-year increase.
Xylem's earnings per share met analyst expectations, which is positive, but the sales miss could be a concern for investors. The year-over-year increase in EPS is a positive sign, but the sales shortfall may weigh on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100